ADVERTISEMENT
Executive Changes
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Kemin Industries founder, human and animal health care innovator RW Nelson dies; Heather Remley moves from BASF’s Global Engineering to North America business helm; and golfer Bryson DeChambeau links up with Bucked Up.
Alvotech has named two new key executives, while Biosimilars Canada has elected its 2025 leaders and the AAM has welcomed the new FDA commissioner in the US.
Leann Sims joins AbundaBox as COO; Oura Ring firm appoints CMO.
Ibis Reproductive Health adds Desiree Williams to lead MORE Study; Radicle Science adds Rob Sinnott as senior strategic advisor; Leann Sims joins AbundaBox as COO; former Cannabis Beverage Association president moves to Vertosa; Vegamour expands executive staff with CMO; and Oura Ring firm appoints CMO.
Veteran pharma executive leads Vitamin Angels; CEO change to lead unifying Dr. Scholl's brand worldwide; and first CEO change for Prinova in 42 years.
HELP Committee members pepper Martin Makary with questions about his investments and potential conflicts of interest as commissioner. Makary’s transparency extends to saying FDA should “use common sense to ask some big questions we've never asked before,” including making more medical products available OTC.
Starboard Value CEO Jeffrey C. Smith and former Bayer consumer health chief Erica Mann among three added to board at Kenvue, which increasing the number of seats temporarily from 11 to 14 until trimming it to 13 at its 2025 annual shareholders meeting on a date yet to be set.
Ashley Graham promotes OLLY; Robles BioCeutics adds financial and science chiefs; Graham Rigby leads AHPA; Vit-Best Nutrition appoints Jeffrey Stallings president; BodyHealth collaborates with NBA player Bam Adebayo; and Bucked Up adds Alex Eubank as brand ambassador.
Along with its 2024 full-year and fourth-quarter results – both down slightly – the Los Angeles-based firm on 19 February announced its board appointed Stephan Gratziani, president since January 2024, as CEO effective 1 May.